Trial by Data

This week we welcome Kyle Holen to Trial by Data to discuss how clinicians can reduce patient burden, the feasibility of siteless trials, and the patient pipeline.

...

Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape. Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.

This week we welcome Noah Craft to Trial by Data to discuss what innovations will enable increased trial participation and trial diversity.

...

Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape. Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.

This week we welcome Noah Craft to Trial by Data to discuss what innovations will enable increased trial participation and trial diversity.

...

Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape. Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.

We welcome Chris Economos to Trial by Data to discuss what it’s going to take for the volume of data we’re gathering to realize its full impact on healthcare, and all of the different players helping us realize this reality.

Chris is the VP of Business Development at PhysIQ, where he leads the commercial operation. Prior to joining physIQ, Chris was part of the leadership team at Healthy Interactions, the global leader in diabetes education and, before that, a marketing manager at AbbVie (formerly Abbott).

You can follow him on Twitter at @physiq4you.

We welcome Chris Economos to Trial by Data to discuss what it’s going to take for the volume of data we’re gathering to realize its full impact on healthcare, and all of the different players helping us realize this reality.

Chris is the VP of Business Development at PhysIQ, where he leads the commercial operation. Prior to joining physIQ, Chris was part of the leadership team at Healthy Interactions, the global leader in diabetes education and, before that, a marketing manager at AbbVie (formerly Abbott).

You can follow him on Twitter at @physiq4you.

This week, we welcome Steve Rosenberg to Trial by Data to discuss the ways clinical trials are being improved through standards, tech, and patient involvement.

...

Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape. Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.

This week, we welcome Steve Rosenberg to Trial by Data to discuss the ways clinical trials are being improved through standards, tech, and patient involvement.

...

Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape. Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.

This week, we welcome Dr. David Rubin to Trial by Data to discuss the changing field of chronic disease management, and new methods of data collection.

Read the full description: https://medium.com/litmus-health-blog/trial-by-data-chronic-diseases-and-data-bd0ad4d1111b

. . .

Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape.

Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.

This week, we welcome Dr. David Rubin to Trial by Data to discuss the changing field of chronic disease management, and new methods of data collection.

Read the full description: https://medium.com/litmus-health-blog/trial-by-data-chronic-diseases-and-data-bd0ad4d1111b

. . .

Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape.

Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.

This week we welcome Joseph Kim, Senior Advisor in Clinical Development Innovation at Eli Lilly, to Trial by Data, to discuss the challenges and opportunities in expanding data collection for clinical trials.

Read the full description: https://medium.com/litmus-health-blog/trial-by-data-expanding-clinical-data-b2cc0a793b16

. . .

Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape. Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.